MYD88 (L265P) mutation is an independent prognostic factor for outcome in patients with diffuse large B-cell lymphoma
Crossref DOI link: https://doi.org/10.1038/leu.2014.184
Published Online: 2014-06-06
Published Print: 2014-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Fernández-Rodríguez, C
Bellosillo, B
García-García, M
Sánchez-González, B
Gimeno, E
Vela, M C
Serrano, S
Besses, C
Salar, A
Text and Data Mining valid from 2014-06-06
Version of Record valid from 2014-06-06
Article History
First Online: 6 June 2014
Competing interests
: The authors declare no conflict of interest.